Literature DB >> 14638515

Genotypes of Pneumocystis jiroveci isolates obtained in Harare, Zimbabwe, and London, United Kingdom.

Robert F Miller1, Austin R Lindley, Helen E Ambrose, Adam S Malin, Ann E Wakefield.   

Abstract

Isolates of Pneumocystis jiroveci from sulfa-exposed and nonexposed patients from London, United Kingdom, and Harare, Zimbabwe, were genotyped. At the dihydropteroate synthase (DHPS) locus, there was evidence of selection pressure from sulfa drug exposure, and reversal of DHPS genotype ratios occurred when selection pressure was absent or was removed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14638515      PMCID: PMC296206          DOI: 10.1128/AAC.47.12.3979-3981.2003

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  19 in total

1.  Geographic distribution of human immunodeficiency virus-associated Pneumocystis carinii pneumonia in San Francisco.

Authors:  A M Morris; M Swanson; H Ha; L Huang
Journal:  Am J Respir Crit Care Med       Date:  2000-11       Impact factor: 21.405

Review 2.  New nomenclature for the genus Pneumocystis.

Authors:  J R Stringer; M T Cushion; A E Wakefield
Journal:  J Eukaryot Microbiol       Date:  2001       Impact factor: 3.346

3.  Pneumocystis carinii f. sp. hominis DNA in immunocompetent health care workers in contact with patients with P. carinii pneumonia.

Authors:  R F Miller; H E Ambrose; A E Wakefield
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

4.  Limited asymptomatic carriage of Pneumocystis jiroveci in human immunodeficiency virus-infected patients.

Authors:  Ann E Wakefield; Austin R Lindley; Helen E Ambrose; Cecile-Marie Denis; Robert F Miller
Journal:  J Infect Dis       Date:  2003-03-06       Impact factor: 5.226

5.  Pneumocystis carinii pneumonia in Zimbabwe.

Authors:  A S Malin; L K Gwanzura; S Klein; V J Robertson; P Musvaire; P R Mason
Journal:  Lancet       Date:  1995-11-11       Impact factor: 79.321

6.  Genetic variation among Pneumocystis carinii hominis isolates in recurrent pneumocystosis.

Authors:  S P Keely; J R Stringer; R P Baughman; M J Linke; P D Walzer; A G Smulian
Journal:  J Infect Dis       Date:  1995-08       Impact factor: 5.226

7.  Asymptomatic carriage of Pneumocystis jiroveci in subjects undergoing bronchoscopy: a prospective study.

Authors:  N A Maskell; D J Waine; A Lindley; J C T Pepperell; A E Wakefield; R F Miller; R J O Davies
Journal:  Thorax       Date:  2003-07       Impact factor: 9.139

8.  Prevention and treatment of Pneumocystis carinii pneumonia in patients infected with HIV.

Authors: 
Journal:  Drug Ther Bull       Date:  1994-02-17

9.  Detection of Pneumocystis carinii with DNA amplification.

Authors:  A E Wakefield; F J Pixley; S Banerji; K Sinclair; R F Miller; E R Moxon; J M Hopkin
Journal:  Lancet       Date:  1990-08-25       Impact factor: 79.321

Review 10.  A new name (Pneumocystis jiroveci) for Pneumocystis from humans.

Authors:  James R Stringer; Charles B Beard; Robert F Miller; Ann E Wakefield
Journal:  Emerg Infect Dis       Date:  2002-09       Impact factor: 6.883

View more
  13 in total

1.  High prevalence of dihydropteroate synthase mutations in Pneumocystis jirovecii isolated from patients with Pneumocystis pneumonia in South Africa.

Authors:  Leigh Dini; Mignon du Plessis; John Frean; Victor Fernandez
Journal:  J Clin Microbiol       Date:  2010-03-29       Impact factor: 5.948

2.  Mutational analysis of Pneumocystis jirovecii dihydropteroate synthase and dihydrofolate reductase genes in HIV-infected patients in China.

Authors:  Xilong Deng; Li Zhuo; Yun Lan; Zhaoxia Dai; Wan-shan Chen; Weiping Cai; Joseph A Kovacs; Liang Ma; Xiaoping Tang
Journal:  J Clin Microbiol       Date:  2014-08-13       Impact factor: 5.948

3.  High Prevalence of Pneumocystis jirovecii Dihydropteroate Synthase Gene Mutations in Patients with a First Episode of Pneumocystis Pneumonia in Santiago, Chile, and Clinical Response to Trimethoprim-Sulfamethoxazole Therapy.

Authors:  Carolina A Ponce; Magali Chabé; Claudio George; Alejandra Cárdenas; Luisa Durán; Julia Guerrero; Rebeca Bustamante; Olga Matos; Laurence Huang; Robert F Miller; Sergio L Vargas
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

4.  Absence of dihydropteroate synthase gene mutations in Pneumocystis jirovecii strains isolated from Aegean region of Turkey.

Authors:  Soykan Ozkoc; Ceren Erguden; Songul Bayram Delibas
Journal:  Parasitol Res       Date:  2018-07-19       Impact factor: 2.289

5.  Genotypic variation in Pneumocystis jirovecii isolates in Britain.

Authors:  R F Miller; A R Lindley; A Copas; H E Ambrose; R J O Davies; A E Wakefield
Journal:  Thorax       Date:  2005-08       Impact factor: 9.139

6.  Prevalence and genotype distribution of Pneumocystis jirovecii in Cuban infants and toddlers with whooping cough.

Authors:  Ernesto X Monroy-Vaca; Yaxsier de Armas; María T Illnait-Zaragozí; Gilda Toraño; Raúl Diaz; Dania Vega; Ileana Alvarez-Lam; Enrique J Calderón; Christen R Stensvold
Journal:  J Clin Microbiol       Date:  2013-10-16       Impact factor: 5.948

Review 7.  Pneumocystis jirovecii pneumonia in developing countries.

Authors:  Y de Armas Rodríguez; G Wissmann; A L Müller; M A Pederiva; M C Brum; R L Brackmann; V Capó de Paz; E J Calderón
Journal:  Parasite       Date:  2011-08       Impact factor: 3.000

Review 8.  Sulfa use, dihydropteroate synthase mutations, and Pneumocystis jirovecii pneumonia.

Authors:  Cheryl R Stein; Charles Poole; Powel Kazanjian; Steven R Meshnick
Journal:  Emerg Infect Dis       Date:  2004-10       Impact factor: 6.883

Review 9.  Dihydropteroate synthase gene mutations in Pneumocystis and sulfa resistance.

Authors:  Laurence Huang; Kristina Crothers; Chiara Atzori; Thomas Benfield; Robert Miller; Meja Rabodonirina; Jannik Helweg-Larsen
Journal:  Emerg Infect Dis       Date:  2004-10       Impact factor: 6.883

10.  Pneumocystis jirovecii dihydropteroate synthase genotypes in immunocompetent infants and immunosuppressed adults, Amiens, France.

Authors:  Anne Totet; Sophie Latouche; Philippe Lacube; Jean-Claude Pautard; Vincent Jounieaux; Christian Raccurt; Patricia Roux; Gilles Nevez
Journal:  Emerg Infect Dis       Date:  2004-04       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.